Earendil Labs

Earendil Labs, the overseas subsidiary of Huashen Zhiyao, was established in December 2024 in Delaware, USA. It is a biotechnology company focused on applying next-generation artificial intelligence to reshape protein therapeutic discovery, with key areas in immunology and oncology. The company has developed a proprietary platform integrating deep learning and high-throughput biology. This platform is an integrated framework combining deep learning, generative protein engineering, structural biology, and high-throughput experimental validation techniques for the efficient discovery and optimization of novel antibodies.